| (Values in U.S. Thousands) | Sep, 2020 | Sep, 2019 | Sep, 2018 | Sep, 2017 | Sep, 2016 |
| Sales | 60,470 | 43,620 | 26,350 | 24,240 | 20,440 |
| Sales Growth | +38.63% | +65.54% | +8.70% | +18.59% | -9.96% |
| Net Income | -4,690 | -790 | -190 | 880 | -3,230 |
| Net Income Growth | -493.67% | -315.79% | -121.59% | +127.24% | -393.64% |
Bioanalytical Syst (BASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Bioanalytical Systems, Inc. is a contract research organization providing research and development resources to many of the leading pharmaceutical, medical device and biotechnology companies in the world. The company offers an efficient, variable-cost alternative to its clients' internal product development, compliance and quality control programs. The company provides a broad array of value-added services and products focused on chemical analysis, allowing its clients to perform their research and development functions either ``in-house`` or at the company.